Tivic Health Systems, Inc. (TIVC)

NASDAQ: TIVC · Real-Time Price · USD
2.810
-0.110 (-3.77%)
At close: Mar 28, 2025, 4:00 PM
2.884
+0.074 (2.62%)
After-hours: Mar 28, 2025, 7:27 PM EDT
-3.77%
Market Cap 1.74M
Revenue (ttm) 780,000
Net Income (ttm) -5.66M
Shares Out 620.14K
EPS (ttm) -19.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,166
Open 2.860
Previous Close 2.920
Day's Range 2.640 - 2.860
52-Week Range 2.640 - 31.450
Beta 1.91
Analysts n/a
Price Target n/a
Earnings Date Mar 21, 2025

About TIVC

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Nov 11, 2021
Employees 9
Stock Exchange NASDAQ
Ticker Symbol TIVC
Full Company Profile

Financial Performance

In 2024, Tivic Health Systems's revenue was $780,000, a decrease of -33.67% compared to the previous year's $1.18 million. Losses were -$5.66 million, -31.40% less than in 2023.

Financial Statements

News

Tivic Health Systems, Inc. (TIVC) Q4 2024 Earnings Call Transcript

Tivic Health Systems, Inc. (NASDAQ:TIVC) Q4 2024 Results Conference Call March 21, 2025 4:30 PM ET Company Participants Jennifer Ernst - Chief Executive Officer Lisa Wolf - Interim Chief Financial Of...

7 days ago - Seeking Alpha

Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced year end December 31, 2024 financial results, highlighted key developm...

7 days ago - Business Wire

Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fig...

15 days ago - Business Wire

Tivic Health and Feinstein Institute Present New Data Showing Personalized Vagus Nerve Stimulation Method Optimizes Impact on Autonomic Nervous System

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today new data that shows personalizing its non-invasive vagus nerve stimula...

22 days ago - Business Wire

Tivic Health Systems, Inc. Announces Reverse Stock Split

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC) (“Tivic Health” or the “Company), a diversified therapeutics company, announced today that its Board of Directors has decla...

23 days ago - Business Wire

Tivic Health Files Patent For Optimized Electrical Stimulation of the Vagus Nerve

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and r...

25 days ago - Business Wire

Tivic Health Names Biotech Industry Veteran Michael K. Handley to Executive Leadership Team

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today that Michael K. Handley, formerly Chief Executive Officer, President a...

4 weeks ago - Business Wire

Tivic Health Acquires Exclusive Worldwide Rights to Phase III TLR5 Agonist from Statera Biopharma

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health Systems, Inc., (Nasdaq: TIVC) today announced it has acquired worldwide exclusive license rights from Statera Biopharma (OTC: STAB) to the late-stage Tol...

6 weeks ago - Business Wire

CEO Letter to Shareholders Issued by Tivic Health

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, today released its annual CEO letter to share...

3 months ago - Business Wire

Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-mont...

4 months ago - Business Wire

Tivic Health Systems, Inc. (TIVC) Q3 2024 Earnings Call Transcript

Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2024 Earnings Conference Call November 14, 2024 4:30 PM ET Company Participants Jennifer Ernst - Chief Executive Officer Operator Welcome to Tivic Health S...

4 months ago - Seeking Alpha

Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been...

4 months ago - Business Wire

Tivic Health Validates European Patents in Great Britain, Germany, and France

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicinal devices, announced today that it has validate...

4 months ago - Business Wire

Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it will report financial re...

5 months ago - Business Wire

First Subject Enrolled in Tivic Health's Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that the first study subject ...

5 months ago - Business Wire

Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that CEO Jennifer Ernst will pr...

5 months ago - Business Wire

Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it has r...

6 months ago - Business Wire

Tivic Health Accelerates VNS Commercial Strategy Development

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced it has partne...

6 months ago - Business Wire

Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, is pleased to announce the ap...

7 months ago - Business Wire

Tivic Health Systems, Inc. (TIVC) Q2 2024 Earnings Call Transcript

Tivic Health Systems, Inc. (NASDAQ:TIVC) Q2 2024 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants Jennifer Ernst - Chief Executive Officer Kimberly Bambach - Interim Chief Fin...

8 months ago - Seeking Alpha

Tivic Reports Second Quarter 2024 Financial Results

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its second quarter 2...

8 months ago - Business Wire

Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced that it will ...

8 months ago - Business Wire

ASM Global Continues Its Live Programming Growth Naming Industry Veteran Ralph Marchetta as Regional Vice President of Live Entertainment

LOS ANGELES--(BUSINESS WIRE)-- #ASMGlobal--ASM Global — the world's No. 1 development and full-service venue company — has named longtime executive Ralph Marchetta to regional vice president of live e...

8 months ago - Business Wire

Tivic Announces 2024 Annual Meeting of Stockholders

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced the Virtual A...

8 months ago - Business Wire

Tivic Health Expands Intellectual Property Portfolio

SAN FRANCISCO--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (“Tivic Health”, Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today that it has r...

8 months ago - Business Wire